From February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
19th April 2022
Switzerland: The Basel-Stadt canton health department has received the green light from the Federal Office of Public Health to start selling recreational cannabis in pharmacies as part of the first such pilot project to receive official approval. A selected 400 participants will be able to buy various cannabis products, including dried flowers and hashish, at certain pharmacies as part of a study into the effects of sales on consumption behaviour and health. The project will start in late summer 2022 and last for two and a half years.
12th April 2022
Switzerland: The Federal Office of Public Health has confirmed to CBD-Intel that the previously reported decision banning chemical products that contain CBD will only affect products that are covered by the chemicals law; it does not apply medicines, e-cigarettes, therapeutic products or foods containing CBD.
8th April 2022
7th April 2022
Switzerland: Representatives of the right-wing Swiss People’s Party and the Federal Democratic Union have submitted a motion to ban the sale of recreational cannabis products in pharmacies in the Bern canton. Such sales are intended to begin on a trial basis this autumn as part of a pilot project to establish a sound basis for possible future decisions on regulation. The proposal to block the trial has now to be analysed by the Executive Council of Bern.